Study questions value of CT screens for lung cancer

Article

Screening CT leads to early lung cancer diagnosis but does not cut lung cancer death rates for people who receive annual screening, according to a large international study.

Screening CT leads to early lung cancer diagnosis but does not cut lung cancer death rates for people who receive annual screening, according to a large international study.

Dr. Peter Bach and colleagues at Memorial Sloan-Kettering Cancer Center in New York City evaluated 3246 asymptomatic men and women with a median age of 60 who had smoked or still smoked for an average of 39 years. Beginning in 1998, subjects underwent screening for lung cancer with multislice CT at the Mayo Clinic in Rochester, MN, the H. Lee Moffitt Cancer Center & Research Institute in Tampa, or Instituto Tumori in Milan, Italy. Subjects received an initial CT scan and then at least three subsequent annual exams.

CT screening found nearly three times as many lung cancers as predicted. However, early detection and treatment did not lead to a decrease in advanced lung cancers or a reduction in deaths from lung cancer (JAMA 2007; 297:953-961).

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.